Clinical trials in Deventer – page 3

73 clinical trials in Deventer, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Deventer at a glance

clinical trials

Research sites1

Quick filters

73 trials in Deventer

Open in trial search

Study on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Dose-Reduced Oxaliplatin and Drug Combination Study for Older Patients with Metastatic Colorectal Cancer

Registered drugNo placebo

The Netherlands

Participants:65+ years
Substances:Capecitabine
Sponsor:Leids Universitair Medisch Centrum (LUMC)

Contact Research Centre

Colorectal cancer metastatic+2

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Study on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Apalutamide
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Study on How Abiraterone Affects Oxycodone in Men with Prostate Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Oxycodone Hydrochloride
Sponsor:Deventer Ziekenhuis

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

Registered drugNo placebo

Study on Docetaxel, Cabazitaxel, and Darolutamide for Men with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cabazitaxel
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational

The Netherlands

Participants:18–64 years
Sponsor:Novo Nordisk A/S

Contact Research Centre

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Diffuse large B-cell lymphoma

Not yet recruiting

Registered drugNo placebo

Epcoritamab plus rituximab versus rituximab alone in elderly, frail or unfit patients with newly diagnosed diffuse large B‑cell lymphoma

Registered drugNo placebo

The Netherlands

Participants:65+ years
Substances:Epcoritamab
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Heart failure with reduced ejection fraction

Not yet recruiting

Investigational

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Crd-4730
Sponsor:Cardurion Pharmaceuticals Inc.

Contact Research Centre

Chronic lymphocytic leukaemia+2

Not yet recruiting

Registered drugNo placebo

Rituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Venetoclax
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Deventer

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on heart failure prevention and treatment of cardiovascular diseases. Studies evaluate new therapeutic approaches for reducing cardiac events and improving patient outcomes.

Heart Failure Prevention
Atherosclerotic Disease Management
Atrial Fibrillation Treatment

Multiple studies examining novel medications and combination therapies for cardiovascular risk reduction.

02 Oncology Studies

Comprehensive research into various cancer types, including urothelial cancer, colorectal liver metastases, and esophageal squamous cell carcinoma.

Advanced Cancer Treatments
Targeted Therapies
Lymphoma Research

Investigating innovative treatment approaches and combination therapies for various cancer types.

03 Respiratory and Immunology

Advanced research in severe asthma treatment and respiratory tract infections. Studies focus on novel therapeutic approaches and treatment optimization.

Eosinophilic Asthma Management
Respiratory Infection Treatment
Immunological Response Studies

Evaluating new treatment protocols and comparing effectiveness of different therapeutic approaches.

Back to the Netherlands All countries